These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8747765

  • 1. Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats.
    Nishikimi T, Tani T, Ohmura T, Yamagishi H, Yanagi S, Yoshiyama M, Toda I, Teragaki M, Akioka K, Takeuchi K.
    Jpn Circ J; 1995 Nov; 59(11):754-61. PubMed ID: 8747765
    [Abstract] [Full Text] [Related]

  • 2. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.
    Nishikimi T, Yamagishi H, Takeuchi K, Takeda T.
    Cardiovasc Res; 1995 Jun; 29(6):856-61. PubMed ID: 7656290
    [Abstract] [Full Text] [Related]

  • 3. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats.
    Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T.
    J Mol Cell Cardiol; 1993 Nov; 25(11):1369-80. PubMed ID: 8301670
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
    Tokioka-Akagi T, Fujimori A, Shibasaki M, Inagaki O, Yanagisawa I.
    Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.
    Mukawa H, Toki Y, Miyazaki Y, Matsui H, Okumura K, Ito T.
    Hypertens Res; 2003 Jan; 26(1):89-95. PubMed ID: 12661917
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
    Chen S, Noguchi Y, Izumida T, Tatebe J, Katayama S.
    J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T.
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [Abstract] [Full Text] [Related]

  • 11. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Ruzicka M, Yuan B, Harmsen E, Leenen FH.
    Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
    [Abstract] [Full Text] [Related]

  • 12. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
    Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T.
    J Hypertens; 1993 Dec; 11(12):1347-55. PubMed ID: 8133017
    [Abstract] [Full Text] [Related]

  • 13. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW, Huang YW, Xia Q, Xu QW.
    Chin Med J (Engl); 2005 Jan 20; 118(2):146-54. PubMed ID: 15667801
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats.
    Nishikimi T, Kawano Y, Saito Y, Matsuoka H.
    J Cardiovasc Pharmacol; 1996 Feb 20; 27(2):275-82. PubMed ID: 8720428
    [Abstract] [Full Text] [Related]

  • 16. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.
    Yamamoto K, Mano T, Yoshida J, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Hori M, Miwa T, Masuyama T.
    J Hypertens; 2005 Feb 20; 23(2):393-400. PubMed ID: 15662228
    [Abstract] [Full Text] [Related]

  • 17. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K, Niimura S, Katoh K, Fukuchi S.
    Life Sci; 1994 Feb 20; 54(25):1987-94. PubMed ID: 8201847
    [Abstract] [Full Text] [Related]

  • 18. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K, Kobayashi N, Watanabe S, Tsubokou Y, Matsuoka H.
    Am J Hypertens; 2001 Apr 20; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [Abstract] [Full Text] [Related]

  • 19. Effects of the new angiotensin receptor antagonist dipotassium (Z)-2-[[5-ethyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl-1,3,4-thiadiazoline-2-ylidene]aminocarbonyl]-1-cy clopentencarbox ylate on experimental cardiac hypertrophy and acute left ventricular failure.
    Murakami M, Inada Y, Tazawa S, Nakao K, Komatsu H.
    Arzneimittelforschung; 1997 Oct 20; 47(10):1099-103. PubMed ID: 9368701
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat.
    Kohara K, Mikami H, Okuda N, Higaki J, Ogihara T.
    Hypertension; 1993 Jun 20; 21(6 Pt 2):975-9. PubMed ID: 8505110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.